drug
as of 2026-07-01TAK-831 Oral Suspension
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Neurocrine Biosciences
1 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
1
A TAK-831-1001, Single and Multiple Rising Dose Study in Healthy Participants
NCT02566759Phase 1Terminated
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
company
indication